BMC Infectious Diseases Volume 3
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Research articlevCJD risk in the Republic of IrelandMichael S Harney1,3 , Azra C Ghani2 , CA Donnelly2 , Rory McConn Walsh3 , Michael Walsh3 , Rachel Howley1 , Francesca Brett1 and Michael Farrell1  1CJD Surveillance Unit, Beaumont Hospital, Dublin, Ireland 2Department of Infectious Disease Epidemiology, Imperial College London, UK 3Department of Otolaryngology, Beaumont Hospital, Dublin, Ireland author email corresponding author email
BMC Infectious Diseases 2003,
3:28doi:10.1186/1471-2334-3-28
|
|
| Published: |
26 November 2003 |
Abstract
Background
The Republic of Ireland has the second highest incidence of BSE worldwide. Only a single case of vCJD has been identified to date.
Methods
We estimate the total future number of clinical cases of vCJD using an established mathematical model, and based on infectivity of bovine tissue calculated from UK data and on the relative exposure to BSE contaminated meat.
Results
We estimate 1 future clinical case (95% CI 0 – 15) of vCJD in the Republic of Ireland. Irish exposure is from BSE infected indigenous beef products and from imported UK beef products. Additionally, 2.5% of the Irish population was exposed to UK beef through residing in the UK during the 'at-risk' period. The relative proportion of risk attributable to each of these three exposures individually is 2:2:1 respectively.
Conclusions
The low numbers of future vCJD cases estimated in this study is reassuring for the Irish population and for other countries with a similar level of BSE exposure. |